Jacques Tebib Selected Research

Jacques Tebib Research Topics

Disease

21	Rheumatoid Arthritis 01/2017 - 02/2002
5	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 02/2002
2	Infections 01/2017 - 10/2010
2	Rheumatic Diseases (Rheumatism) 01/2017 - 02/2002
2	Necrosis 10/2010 - 01/2009
2	Ankylosing Spondylitis 10/2010 - 07/2007
2	Psoriatic Arthritis 10/2009 - 10/2009
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2009 - 08/2007
2	Pain (Aches) 06/2009 - 09/2003
2	Crohn Disease (Crohn's Disease) 01/2008 - 08/2007
2	Bone Resorption 01/2008 - 03/2007
2	Inflammation (Inflammations) 01/2008 - 07/2006
1	Arthritis (Polyarthritis) 12/2010
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 10/2010
1	Hip Osteoarthritis (Coxarthrosis) 06/2009
1	Multiple Sclerosis 01/2008
1	Mycobacterium Infections (Infections, Mycobacterium) 01/2008
1	Granuloma 01/2008
1	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2007
1	Myositis (Idiopathic Inflammatory Myopathies) 08/2007
1	Antisynthetase syndrome 08/2007
1	Heart Failure 07/2006
1	Osteoarthritis 10/2005
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 08/2003
1	Bacterial Infections (Bacterial Infection) 08/2003
1	Pneumonia (Pneumonitis) 08/2003

Drug/Important Bio-Agent (IBA)

7	Rituximab (Mabthera)FDA Link 01/2017 - 04/2011
5	AutoantibodiesIBA 01/2017 - 02/2002
5	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 08/2003
5	Antirheumatic Agents (DMARD)IBA 01/2017 - 10/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 12/2004
3	GlucocorticoidsIBA 12/2010 - 07/2006
2	Biological ProductsIBA 01/2017 - 10/2009
2	B-Cell Activating FactorIBA 04/2013 - 07/2009
2	Biomarkers (Surrogate Marker)IBA 04/2011 - 02/2002
2	Interleukin-17 (Interleukin 17)IBA 07/2009 - 01/2008
2	Hyaluronic Acid (Hyaluronan)IBA 06/2009 - 12/2004
2	CytokinesIBA 01/2008 - 12/2004
1	InterferonsIBA 01/2017
1	STAT4 Transcription FactorIBA 01/2017
1	tocilizumab (atlizumab)FDA Link 01/2017
1	ametantrone (HAQ)IBA 01/2017
1	Factor V (Coagulation Factor V)IBA 01/2017
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2017
1	OsteopontinIBA 01/2017
1	ChemokinesIBA 09/2013
1	Monoclonal AntibodiesIBA 04/2011
1	Tumor Necrosis Factor InhibitorsIBA 10/2010
1	triamcinolone hexacetonide (Aristospan)FDA Link 10/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2010
1	Prostaglandins AIBA 06/2009
1	masitinibIBA 01/2009
1	LigandsIBA 01/2008
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2008
1	Histidine-tRNA LigaseIBA 08/2007
1	Proteins (Proteins, Gene)FDA Link 07/2007
1	Carbonic Anhydrase IIIIBA 07/2007
1	AutoantigensIBA 07/2007
1	Interleukin-2 (IL2)IBA 03/2007
1	Tartrate-Resistant Acid PhosphataseIBA 03/2007
1	Interleukin-4 (Interleukin 4)IBA 03/2007
1	Interleukin-10 (Interleukin 10)IBA 03/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2006
1	LDL CholesterolIBA 07/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2006
1	CholesterolIBA 07/2006
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2005
1	Angiotensin Receptor AntagonistsIBA 10/2005
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2005
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2005
1	DiureticsIBA 10/2005
1	AnticoagulantsIBA 10/2005
1	Interleukin-1 (Interleukin 1)IBA 12/2004
1	GadoliniumIBA 09/2003
1	Pharmaceutical PreparationsIBA 08/2003
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2003

Therapy/Procedure

8	Therapeutics 01/2016 - 10/2005
2	Biological Therapy 10/2009 - 07/2007
1	Retreatment 08/2014
1	Intra-Articular Injections 06/2009
1	Viscosupplementation 06/2009
1	Drug Therapy (Chemotherapy) 07/2007